{
  "docId": "019de075-2cce-7280-b26a-b6cf6a81cc60",
  "docSlug": "0ebab7f84cc526493dad2db7df8c89e5",
  "documentTitle": "MindMed | Investor Day Presentation Deck | 61 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 50,
  "pageCount": 61,
  "prevPage": 49,
  "nextPage": 51,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a Gantt-style chart to show the progress of various drug candidates through clinical development stages.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-2cce-7280-b26a-b6cf6a81cc60/50",
  "deckHref": "/decks/019de075-2cce-7280-b26a-b6cf6a81cc60",
  "deckJsonHref": "/decks/019de075-2cce-7280-b26a-b6cf6a81cc60.json",
  "deckAnchorHref": "/decks/019de075-2cce-7280-b26a-b6cf6a81cc60#slide-50",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.857,
        "x": 0.057,
        "y": 0.17
      },
      "kind": "chart",
      "text": "Pipeline progress bars",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4a19a2e-18b2-472f-870d-839ed7171ece",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.057,
        "y": 0.82
      },
      "kind": "disclaimer",
      "text": "* Continued development of MM-110 is currently subject to the Company obtaining non-dilutive sources of capital and/or collaboration partners. ** Full trial details and clinical trials.gov links available at mindmed.co/clinical-digital-trials/.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "130bef34-8a26-4926-bfe6-0031f4f5dded",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.47,
        "x": 0.057,
        "y": 0.88
      },
      "kind": "subtitle",
      "text": "ADHD: Attention-Deficit/Hyperactivity Disorder; LSD: lysergic acid diethylamide; MDMA: 3,4-methylenedioxymethamphetamine.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "582c3572-c4a8-429e-be03-59d07ed32cfe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.465,
        "x": 0.057,
        "y": 0.05
      },
      "kind": "title",
      "text": "Research & Development Pipeline",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00af449f-90a2-4531-a6b8-e168f420e875",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "61b4a66e-8d02-4c68-b597-70ed812fcbfb",
      "evidence": "The slide uses horizontal bars to represent the duration and phase of clinical trials for various drug candidates.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 50,
      "from": 47,
      "name": "Mece Breakdown",
      "slug": "40-mece-breakdown",
      "bestFor": "Problem structuring, ensuring completeness, strategic analysis",
      "matchId": "dab391d4-3477-402c-bcb9-86ef9025b6ca",
      "evidence": "The presentation provides a breakdown of the R&D pipeline and its potential.",
      "position": 2,
      "objective": "How does MindMed's R&D pipeline address the market need?",
      "structure": "The Whole -> Category A (distinct) -> Category B (distinct) -> Category C (distinct) -> Complete Coverage",
      "confidence": 0.6,
      "description": "Divide a complex topic into mutually exclusive, collectively exhaustive categories"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}